Literature DB >> 3232865

Evaluation of breed as a risk factor for sarcoid and uveitis in horses.

J Angelos1, Y Oppenheim, W Rebhun, H Mohammed, D F Antczak.   

Abstract

The relationship between breed and the risk of developing sarcoid tumours or uveitis of unknown etiology was evaluated in a retrospective study of 16242 equine cases admitted between 1975 and 1987 to the New York State College of Veterinary Medicine Large Animal Hospital, and 3198 equine tissue samples sent to the New York State Veterinary Diagnostic Laboratory between 1977 and 1987. Of 120 sarcoid cases from the Large Animal Hospital, sarcoids were twice as likely to develop in Quarter Horses (odds ratio, OR = 1.8, P less than 0.05) relative to Thoroughbreds and less than half as likely to develop in Standardbreds (OR = 0.2, P less than 0.001) relative to Thoroughbreds. Similarly, of 376 sarcoid cases from the Diagnostic Laboratory, Quarter Horses had a significantly higher risk of developing sarcoid (OR = 2.0, P less than 0.001) relative to Thoroughbreds, while Standardbreds had a significantly lower risk of developing sarcoid (OR = 0.5, P less than 0.05) relative to Thoroughbreds. In the uveitis diagnosis category, Appaloosas had a significantly higher risk of developing uveitis (OR = 6.4, P less than 0.001) relative to Thoroughbreds, while Standardbreds had a significantly lower risk of developing uveitis (OR = 0.4, P less than 0.05) relative to Thoroughbreds.

Entities:  

Mesh:

Year:  1988        PMID: 3232865     DOI: 10.1111/j.1365-2052.1988.tb00833.x

Source DB:  PubMed          Journal:  Anim Genet        ISSN: 0268-9146            Impact factor:   3.169


  12 in total

1.  Longitudinal and cross-sectional studies to evaluate the risk of sarcoid associated with castration.

Authors:  S W Reid; H O Mohammed
Journal:  Can J Vet Res       Date:  1997-04       Impact factor: 1.310

2.  Equine recurrent uveitis in western Canadian prairie provinces: A retrospective study (2002-2015).

Authors:  Lynne S Sandmeyer; Bianca S Bauer; Cindy Xin Feng; Bruce H Grahn
Journal:  Can Vet J       Date:  2017-07       Impact factor: 1.008

3.  Epidemiology of equine sarcoids in horses in western Canada.

Authors:  Bruce K Wobeser; Jennifer L Davies; Janet E Hill; Marion L Jackson; Beverly A Kidney; Monique N Mayer; Hugh G G Townsend; Andrew L Allen
Journal:  Can Vet J       Date:  2010-10       Impact factor: 1.008

4.  Carbon dioxide laser as a surgical instrument for sarcoid therapy--a retrospective study on 60 cases.

Authors:  B Carstanjen; P Jordan; O M Lepage
Journal:  Can Vet J       Date:  1997-12       Impact factor: 1.008

Review 5.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

6.  Characterization of BPV-like DNA in equine sarcoids.

Authors:  J A Angelos; E Marti; S Lazary; L E Carmichael
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Equine sarcoids. A clinical and epidemiological study in relation to equine leucocyte antigens (ELA).

Authors:  H Broström
Journal:  Acta Vet Scand       Date:  1995       Impact factor: 1.695

8.  Multiple excisions of an equine sarcoid and the repercussions.

Authors:  Heather Melinyshyn
Journal:  Can Vet J       Date:  2019-10       Impact factor: 1.008

9.  Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression.

Authors:  J Lacy Kamm; Natalie A Parlane; Christopher B Riley; Erica K Gee; Keren E Dittmer; C Wayne McIlwraith
Journal:  PLoS One       Date:  2019-11-20       Impact factor: 3.240

10.  A genome-wide association study identifies risk loci to equine recurrent uveitis in German warmblood horses.

Authors:  Maike Kulbrock; Stefanie Lehner; Julia Metzger; Bernhard Ohnesorge; Ottmar Distl
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.